Literature DB >> 10087432

Enoxaparin reduces cerebral edemaafter photothrombotic injury in the rat.

J Pratt1, P Boudeau, A Uzan, A Imperato, J Stutzmann.   

Abstract

This study investigates the effect of enoxaparin (Lovenox, Klexane), a low-molecular-weight heparin, on edema following a photothrombotic lesion using rose bengal dye in the rat. An area of cerebral ischemia was provoked in the right hemisphere of rats. Edema developed over 24 h after the lesion, as seen comparing water content of a core sample from the right hemisphere to that of a similar sample from the left hemisphere of each rat. Enoxaparin at 0. 5 mg/kg i.v. plus 2 mg/kg s.c. reduced edema 24 h after lesion induction by 32% (p < 0.01) when the treatment was started 2 h after photothrombotic insult, with maintenance doses of 2 mg/kg s.c. enoxaparin at 6 and 18 h. When the same initial treatment with enoxaparin was started 18 h after insult, there was still a significant reduction of 20% (p < 0.01) in cerebral edema. Administration of enoxaparin 18 h after insult reduced cerebral edema in a dose-dependent manner. There was no evidence of intracranial hemorrhages in any of the animal groups and when the hemoglobin content of the brain samples was assayed by the method of Drabkin, no increase in hemoglobin content was seen compared to sham-operated animals.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 10087432     DOI: 10.1159/000022416

Source DB:  PubMed          Journal:  Haemostasis        ISSN: 0301-0147


  6 in total

Review 1.  [Acute ischemic stroke. New approaches to antithrombotic treatment].

Authors:  P Kraft; B Nieswandt; G Stoll; C Kleinschnitz
Journal:  Nervenarzt       Date:  2012-04       Impact factor: 1.214

2.  Enoxaparin ameliorates post-traumatic brain injury edema and neurologic recovery, reducing cerebral leukocyte endothelial interactions and vessel permeability in vivo.

Authors:  Shengjie Li; Joshua A Marks; Rachel Eisenstadt; Kenichiro Kumasaka; Davoud Samadi; Victoria E Johnson; Daniel N Holena; Steven R Allen; Kevin D Browne; Douglas H Smith; Jose L Pascual
Journal:  J Trauma Acute Care Surg       Date:  2015-07       Impact factor: 3.313

Review 3.  Next-generation antithrombotics in ischemic stroke: preclinical perspective on 'bleeding-free antithrombosis'.

Authors:  Peter Kraft; Simon F De Meyer; Christoph Kleinschnitz
Journal:  J Cereb Blood Flow Metab       Date:  2012-07-18       Impact factor: 6.200

4.  Biosensors for brain trauma and dual laser doppler flowmetry: enoxaparin simultaneously reduces stroke-induced dopamine and blood flow while enhancing serotonin and blood flow in motor neurons of brain, in vivo.

Authors:  Patricia A Broderick; Edwin H Kolodny
Journal:  Sensors (Basel)       Date:  2010-12-24       Impact factor: 3.576

5.  Dose-dependent neuroprotective effect of enoxaparin on cold-induced traumatic brain injury.

Authors:  Ilknur Keskin; M Yalcin Gunal; Nilufer Ayturk; Ulkan Kilic; Mehmet Ozansoy; Ertugrul Kilic
Journal:  Neural Regen Res       Date:  2017-05       Impact factor: 5.135

Review 6.  Heparin and Heparin-Derivatives in Post-Subarachnoid Hemorrhage Brain Injury: A Multimodal Therapy for a Multimodal Disease.

Authors:  Erik G Hayman; Akil P Patel; Robert F James; J Marc Simard
Journal:  Molecules       Date:  2017-05-02       Impact factor: 4.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.